Eiger BioPharmaceuticals, Inc.

Eiger is a biopharmaceutical company developing new antiviral agents againstnovel targets in the treatment of hepatitis.

Founded

2008

Raised

$28M

Follow us

Companies in the same industry

Alexa global traffic share

Index